Rasagiline -- is there a place for this drug in managing Parkinson's disease?
作者信息
Sharma Jagdish C
出版信息
Int J Clin Pract. 2006 Feb;60(2):132-3. doi: 10.1111/j.1742-1241.2006.00843d.x.
Abstract
摘要
相似文献
1
Rasagiline -- is there a place for this drug in managing Parkinson's disease?
Int J Clin Pract. 2006 Feb;60(2):132-3. doi: 10.1111/j.1742-1241.2006.00843d.x.
2
Rasagiline as a therapy for Parkinson's disease (PD).
Am J Geriatr Pharmacother. 2007 Jun;5(2):174-5; author reply 175-6. doi: 10.1016/j.amjopharm.2007.06.002.
3
Rasagiline. Parkinson's disease: a simple me-too.
Prescrire Int. 2006 Dec;15(86):220.
4
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
Clin Ther. 2007 Sep;29(9):1825-49. doi: 10.1016/j.clinthera.2007.09.021.
5
[Rasagiline in motor fluctuations].
Fortschr Neurol Psychiatr. 2005 Sep;73(9):488.
6
New drug treatment for Parkinson's disease.
FDA Consum. 2006 Jul-Aug;40(4):7.
7
[Rasagiline: effectiveness and protection in Parkinson's disease].
Rev Neurol. 2010 Nov 1;51(9):535-41.
8
Rasagiline in Parkinson's disease.
Int Rev Neurobiol. 2011;100:151-68. doi: 10.1016/B978-0-12-386467-3.00008-X.
9
Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.
Am J Geriatr Pharmacother. 2006 Dec;4(4):330-46. doi: 10.1016/j.amjopharm.2006.12.001.
10
Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's disease.
Int J Clin Pract. 2006 Feb;60(2):215-21. doi: 10.1111/j.1742-1241.2006.00806.x.
Zotero 插件